- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs for the treatment of mucopolysaccharidoses
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 21, Issue 1, Pages 9-26
Publisher
Informa Healthcare
Online
2016-01-09
DOI
10.1517/14728214.2016.1123690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient
- (2015) Joyce E. Fox et al. MOLECULAR GENETICS AND METABOLISM
- Early treatment is associated with improved cognition in Hurler syndrome
- (2014) Michele D. Poe et al. ANNALS OF NEUROLOGY
- Insulin receptor antibody-iduronate 2-sulfatase fusion protein: Pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys
- (2014) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Gene delivery strategies for the treatment of mucopolysaccharidoses
- (2014) Guilherme Baldo et al. Expert Opinion on Drug Delivery
- Current and potential therapeutic strategies for mucopolysaccharidoses
- (2014) H. Noh et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain
- (2014) Barbara King et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study
- (2014) Christian J. Hendriksz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
- (2014) Christian J Hendriksz et al. Orphanet Journal of Rare Diseases
- Laronidase-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Promising Formulation for a More Effective Treatment of Mucopolysaccharidosis Type I
- (2014) Fabiana Quoos Mayer et al. PHARMACEUTICAL RESEARCH
- Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment
- (2014) Michael Frohbergh et al. PLoS One
- Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
- (2014) S.-h. Kan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improvement of CNS Defects Via Continuous Intrathecal Enzyme Replacement by Osmotic Pump in Mucopolysaccharidosis Type II Mice
- (2013) Young Bae Sohn et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts
- (2013) Shih-hsin Kan et al. BIOCHEMICAL JOURNAL
- Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
- (2013) Virginia Haurigot et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment of MPS I mice with microencapsulated cells overexpressing IDUA: effect of the prednisolone administration
- (2013) Valeska Lizzi Lagranha et al. JOURNAL OF MICROENCAPSULATION
- Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: Assessment of effects on cognitive functions and general status of patients
- (2013) Ewa Piotrowska et al. MEDICAL SCIENCE MONITOR
- High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system
- (2013) Katherine H. Kim et al. MOLECULAR GENETICS AND METABOLISM
- Mucopolysaccharidosis IVA: Correlation between genotype, phenotype and keratan sulfate levels
- (2013) Vũ Chí Dũng et al. MOLECULAR GENETICS AND METABOLISM
- Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome)
- (2013) Young Bae Sohn et al. Orphanet Journal of Rare Diseases
- Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
- (2013) Edward H. Schuchman et al. PLoS One
- Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression
- (2013) Kim M. Keeling et al. PLoS One
- Therapies of mucopolysaccharidosis IVA (Morquio A syndrome)
- (2013) Shunji Tomatsu et al. Expert Opinion on Orphan Drugs
- Putative Biological Mechanisms of Efficiency of Substrate Reduction Therapies for Mucopolysaccharidoses
- (2012) Zyta Banecka-Majkutewicz et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-l-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice
- (2012) Guilherme Baldo et al. CYTOTHERAPY
- Gene Therapy for Mucopolysaccharidosis Type VI Is Effective in Cats Without Pre-Existing Immunity to AAV8
- (2012) Rita Ferla et al. HUMAN GENE THERAPY
- A Genetic Model of Substrate Reduction Therapy for Mucopolysaccharidosis
- (2012) William C. Lamanna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficits
- (2012) Guilherme Baldo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Pharmacological read-through of nonsense ARSB mutations as a potential therapeutic approach for mucopolysaccharidosis VI
- (2012) Rosa Bartolomeo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model
- (2012) Daniel J. Rowan et al. MOLECULAR GENETICS AND METABOLISM
- Long Term Outcomes of a Phase 1/2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome)
- (2012) Christian Hendriksz et al. MOLECULAR GENETICS AND METABOLISM
- Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I
- (2012) Patricia I. Dickson et al. MOLECULAR GENETICS AND METABOLISM
- Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: A nationwide survey in Japan
- (2012) Akemi Tanaka et al. MOLECULAR GENETICS AND METABOLISM
- Sialic Acid Deposition Impairs the Utility of AAV9, but Not Peptide-modified AAVs for Brain Gene Therapy in a Mouse Model of Lysosomal Storage Disease
- (2012) Yong Hong Chen et al. MOLECULAR THERAPY
- Neonatal Gene Therapy With a Gamma Retroviral Vector in Mucopolysaccharidosis VI Cats
- (2012) Katherine P Ponder et al. MOLECULAR THERAPY
- Intracisternal enzyme replacement therapy in lysosomal storage diseases: dispersal pathways, regional enzyme concentrations and the effect of posttreatment posture
- (2012) R. D. Jolly et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder
- (2012) Pericles Calias et al. PLoS One
- Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII
- (2012) H. T. Huynh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genistein in Sanfilippo disease: A randomized controlled crossover trial
- (2011) Jessica de Ruijter et al. ANNALS OF NEUROLOGY
- Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Emerging Treatment Strategies
- (2011) J. de Ruijter et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Helper-dependent canine adenovirus vector-mediated transgene expression in a neurodegenerative lysosomal storage disorder
- (2011) Adeline A. Lau et al. GENE
- Genistein supplementation in patients affected by Sanfilippo disease
- (2011) Verónica Delgadillo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases
- (2011) Ursula Matte et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation
- (2011) Guilherme Baldo et al. MOLECULAR GENETICS AND METABOLISM
- Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery
- (2011) Haiyan Fu et al. MOLECULAR THERAPY
- Enzyme replacement reduces neuropathology in MPS IIIA dogs
- (2011) Allison C. Crawley et al. NEUROBIOLOGY OF DISEASE
- Safety Evaluation of Chronic Intrathecal Administration of Idursulfase-IT in Cynomolgus Monkeys
- (2011) Brian R. Felice et al. TOXICOLOGIC PATHOLOGY
- Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype-phenotype correlations
- (2010) Marlies J. Valstar et al. ANNALS OF NEUROLOGY
- THE NATURAL HISTORY OF THE SEVERE FORM OF HUNTER'S SYNDROME: A STUDY BASED ON 52 CASES
- (2010) I. D. Young et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
- (2010) Joseph Muenzer et al. GENETICS IN MEDICINE
- Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
- (2010) N Matthew Ellinwood et al. MOLECULAR THERAPY
- Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I
- (2010) Mark J Osborn et al. MOLECULAR THERAPY
- Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy
- (2010) Sung-Chul Jung et al. MOLECULES AND CELLS
- Intracisternal enzyme replacement therapy in lysosomal storage diseases: routes of absorption into brain
- (2010) R. D. Jolly et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides
- (2010) Célia Floquet et al. NUCLEIC ACIDS RESEARCH
- Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease
- (2010) Marcelina Malinowska et al. PLoS One
- Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB
- (2009) Carmela Di Domenico et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status
- (2009) Sema Kalkan Ucar et al. BRAIN & DEVELOPMENT
- Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs—A proof of principle study
- (2009) Kim M. Hemsley et al. MOLECULAR GENETICS AND METABOLISM
- Systemic Correction of Storage Disease in MPS I NOD/SCID Mice Using the Sleeping Beauty Transposon System
- (2009) Elena L Aronovich et al. MOLECULAR THERAPY
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- Involvement of the Toll-like receptor 4 pathway and use of TNF- antagonists for treatment of the mucopolysaccharidoses
- (2009) C. M. Simonaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence
- (2008) Gunilla Malm et al. ACTA PAEDIATRICA
- Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression
- (2008) Maria-Veronica Munoz-Rojas et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Lysosomal Storage Diseases and the Blood-Brain Barrier
- (2008) David Begley et al. CURRENT PHARMACEUTICAL DESIGN
- Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy
- (2008) Marjanke A. Hoving et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice
- (2008) K. M. Hemsley et al. GENES BRAIN AND BEHAVIOR
- Sanfilippo syndrome: A mini-review
- (2008) M. J. Valstar et al. JOURNAL OF INHERITED METABOLIC DISEASE
- In vitro correction of ARSA deficiency in human skin fibroblasts from Metachromatic Leukodystrophy patients after treatment with microencapsulated recombinant cells
- (2008) Valeska Lizzi Lagranha et al. METABOLIC BRAIN DISEASE
- Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA
- (2008) Chantelle McIntyre et al. MOLECULAR GENETICS AND METABOLISM
- Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
- (2008) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I
- (2008) L. A. Clarke et al. PEDIATRICS
- Chemically modified -glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII
- (2008) J. H. Grubb et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biochemical, Pathological, and Skeletal Improvement of Mucopolysaccharidosis VI After Gene Transfer to Liver but Not to Muscle
- (2007) Alessandra Tessitore et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started